VanEck Rare Earth and Strategic Metals UCITS ETF

The Product's investment objective is to replicate, before fees and expenses, the MVIS Global Rare Earth/Strategic Metals Index (the "Index"). In order to seek to achieve its investment objective, the Manufacturer will use a replication strategy by investing directly in the underlying equity securities of the Index being the stock, American depository receipts (ADRs), and global depository receipts (GDRs). Such equity securities must be issued by companies listed or traded on the Markets referred to in Appendix II of the Prospectus who generate at least 50% of their revenues from rare earth / strategic metals or companies that generate at least 50% of their revenues from rare earth / strategic metals through mining mineral resources. For the avoidance of doubt, where the Index already holds such equity securities, the Index will seek to remove the security when the percentage of revenue generated from the rare earth / strategic metals companies drops below 25% of the relevant company's revenues. The Product may invest up to 60% of its Net Asset Value directly in shares issued by companies listed on the Shanghai Stock Exchange or the Shenzhen Stock Exchange. Where it is not practical or cost efficient for the Fund to fully replicate the Index, the Manager may utilise an optimised sampling methodology. The Product may invest more than 20% of its Net Asset Value in emerging markets and may also (or alternatively) invest in financial derivative instruments (FDIs) which relate to the Index or constituents of the Index. The FDIs which the Product may use are futures, options (puts and calls) swaps (equity swaps and swaps on the Index), currency forwards and non-deliverable forwards (a forward contract that does not require settlement on maturity) (NDFs). The Product invests in the underlying (physical) securities that make up the Index and does not take part in securities lending. The Product may also invest in ancillary liquid assets and money market instruments which

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No